Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Pulmonary Arterial Remodeling

Known as: Remodeling, Pulmonary Arterial, Pulmonary Arterial Remodelings, Arterial Remodelings, Pulmonary 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Pulmonary arterial hypertension (PAH) is a progressive fatal disease caused by pulmonary arterial remodeling. Midkine regulates… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2017
2017
Pulmonary artery hypertension (PAH) is a chronic and deadly disease, for which effective medical treatments are lacking. Here, we… Expand
2015
2015
Prostaglandin I2 (PGI2) and its analogues (such as beraprost sodium, BPS) are beneficial for the treatment of pulmonary arterial… Expand
2013
2013
Elevated reactive oxygen species are implicated in pulmonary hypertension (PH). Superoxide dismutase (SOD) limits superoxide… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2012
2012
OBJECTIVES Pulmonary arterial hypertension (PAH) is a rare and severe disease with incompletely under stood pathogenesis. PAH is… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4